HMF Child

Child-specific high potency chewable probiotic
HMF Child is a delicious, naturally flavoured blackcurrant chewable tablet. Probiotics help contribute to a natural healthy gut flora.

High potency probiotic
Contains 12.5 billion CFU*/serving clinically. proven probiotic strains.

Great child-appeal increases compliance
Natural blackcurrant flavour.

Serving Size: 1 Chewable Tablet
Servings Per Container: 30

Active Ingredients:

Probiotic Consortium 12.5 billion CFU
• Lactobacillus acidophilus (CUL-60)
• Lactobacillus acidophilus (CUL-21)
• Bifidobacterium bifidum (CUL-20)
• Bifidobacterium animalis subsp. lactis (CUL-34)
• Lactobacillus salivarius (CUL-61)
• Lactobacillus paracasei (CUL-08)

Inactive Ingredients: Sorbitol, xylitol, blackcurrant flavour, silica, magnesium stearate.

Recommended Dosage:
Children (4 years and older): Chew one tablet two times daily with meals, or as recommended by your healthcare practitioner

Risk information: If you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain; or if you have an immune-compromised condition, do not use. If symptoms of digestive upset occur, worsen or persist beyond three days discontinue use and consult your healthcare practitioner.

This product does not contain: wheat, gluten, dairy, soy, corn, fish, shellfish, peanuts, tree nuts, eggs, artificial colors, flavors or preservatives.  

Seroyal research-driven probiotic therapies:

• Clinically proven in randomized, double-blind, placebo-controlled adult human trials at 25 billion CFU to:
  • Reduce symptoms of Irritable Bowel Syndrome (IBS)1
  • Prevent intestinal microflora disruption post antibiotics2, 3
  • Reduce the incidence of C. difficile associated diarrhoea (Pilot study)4
• Proprietary non-pathogenic human-sourced microflora bacterial strains have:
  • Strong epithelial adherence
  • Naturally high tolerance to stomach acid

References:

1. Williams EA, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 2009; 29(1): 97-103.
2. Plummer SF, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005; 26(1); 69-74.
3. Madden JA, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005; (6): 1091-7.
4. Plummer S, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7(1):59-62.